William Canfield is a glycobiologist, chief scientific officer and founder of an Oklahoma City-based biotechnology company, Novazyme, which was acquired by Genzyme in August 2001 and developed, among other things, an enzyme that can stabilize (but not cure) Pompe disease, based on Canfield's ongoing research since 1998. Canfield subsequently left Genzyme and established, with his partner in the Novazyme operation, John Crowley, another research laboratory, which he still heads. He saved Cytovance from bankruptcy by forming an investor group and raising $9 million after Crowley suddenly left the lab in 2005 to become the chief executive officer at Amicus Therapeutics in New Jersey
| Property |
Value |
| dbo:abstract |
William Canfield is a glycobiologist, chief scientific officer and founder of an Oklahoma City-based biotechnology company, Novazyme, which was acquired by Genzyme in August 2001 and developed, among other things, an enzyme that can stabilize (but not cure) Pompe disease, based on Canfield's ongoing research since 1998. Canfield subsequently left Genzyme and established, with his partner in the Novazyme operation, John Crowley, another research laboratory, which he still heads. He saved Cytovance from bankruptcy by forming an investor group and raising $9 million after Crowley suddenly left the lab in 2005 to become the chief executive officer at Amicus Therapeutics in New Jersey (en) |
| dbo:wikiPageID |
25152392 (xsd:integer) |
| dbo:wikiPageLength |
4186 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1072942165 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Biochemistry dbc:University_of_Puget_Sound_alumni dbr:University_of_Oklahoma_Health_Sciences_Center dbr:University_of_Puget_Sound dbr:University_of_Washington dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbr:Orphan_drug dbr:Genzyme dbr:Glycogen_storage_disease_type_II dbr:B.S. dbc:American_medical_researchers dbc:University_of_Oklahoma_faculty dbr:Doctor_of_Medicine dbr:Alglucosidase_alfa dbr:Duke_University dbr:Extraordinary_Measures dbr:Food_and_Drug_Administration_(United_States) dbr:Glycobiology dbr:Harrison_Ford dbr:Yuan-Tsong_Chen dbr:Chemistry dbc:University_of_Washington_School_of_Medicine_alumni dbr:John_Crowley_(biotech_executive) dbr:Ph.D. dbr:New_Jersey dbr:Pompe_disease dbr:Cytovance_Biologics |
| dbp:wikiPageUsesTemplate |
dbt:For dbt:Reflist |
| dcterms:subject |
dbc:University_of_Puget_Sound_alumni dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbc:American_medical_researchers dbc:University_of_Oklahoma_faculty dbc:University_of_Washington_School_of_Medicine_alumni |
| rdf:type |
yago:WikicatAmericanMedicalResearchers yago:WikicatLivingPeople yago:CausalAgent100007347 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:ResearchWorker110523076 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Scientist110560637 yago:Whole100003553 |
| rdfs:comment |
William Canfield is a glycobiologist, chief scientific officer and founder of an Oklahoma City-based biotechnology company, Novazyme, which was acquired by Genzyme in August 2001 and developed, among other things, an enzyme that can stabilize (but not cure) Pompe disease, based on Canfield's ongoing research since 1998. Canfield subsequently left Genzyme and established, with his partner in the Novazyme operation, John Crowley, another research laboratory, which he still heads. He saved Cytovance from bankruptcy by forming an investor group and raising $9 million after Crowley suddenly left the lab in 2005 to become the chief executive officer at Amicus Therapeutics in New Jersey (en) |
| rdfs:label |
William Canfield (en) |
| owl:sameAs |
freebase:William Canfield yago-res:William Canfield wikidata:William Canfield https://global.dbpedia.org/id/4xroZ |
| prov:wasDerivedFrom |
wikipedia-en:William_Canfield?oldid=1072942165&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:William_Canfield |
| is dbo:wikiPageRedirects of |
dbr:Canfield,_William dbr:Robert_Stonehill |
| is dbo:wikiPageWikiLink of |
dbr:Canfield,_William dbr:University_of_Puget_Sound dbr:Stampede_in_the_Night dbr:Robert_Stonehill dbr:Extraordinary_Measures dbr:Henri_Termeer dbr:John_Crowley_(biotech_executive) dbr:Canfield_(surname) |
| is foaf:primaryTopic of |
wikipedia-en:William_Canfield |